> top > docs > PMC:7253482 > spans > 0-451 > annotations

PMC:7253482 / 0-451 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2 19-30 Species denotes coronavirus Tax:11118
3 31-37 Chemical denotes glycan MESH:D011134
25 133-186 Species denotes Middle East respiratory syndrome (MERS) coronaviruses Tax:1335626
26 188-192 Species denotes CoVs Tax:11118
27 391-402 Species denotes Coronavirus Tax:11118
33 367-372 Gene denotes spike Gene:43740568
39 88-121 Disease denotes Severe acute respiratory syndrome MESH:D045169
40 123-127 Disease denotes SARS MESH:D045169
41 198-206 Disease denotes zoonotic MESH:D015047

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 377-389 Body_part denotes glycoprotein http://purl.org/sig/ont/fma/fma62925
T2 405-413 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 88-121 Disease denotes Severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T2 123-127 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 286-293 http://purl.obolibrary.org/obo/CLO_0009985 denotes focuses

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 377-389 Chemical denotes glycoprotein http://purl.obolibrary.org/obo/CHEBI_17089
T2 405-413 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T1 207-216 http://purl.obolibrary.org/obo/IDO_0000528 denotes pathogens
T2 338-361 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune response
T3 346-361 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T0 0-15 NNS denotes Vulnerabilities
T1 16-18 IN denotes in
T2 19-30 NN denotes coronavirus
T3 31-37 NN denotes glycan
T4 38-45 NNS denotes shields
T5 46-53 IN denotes despite
T6 54-63 JJ denotes extensive
T7 64-77 NN denotes glycosylation
T8 79-87 NN denotes Abstract
T9 88-94 JJ denotes Severe
T10 95-100 JJ denotes acute
T11 101-112 JJ denotes respiratory
T12 113-121 NN denotes syndrome
T13 122-123 -LRB- denotes (
T14 123-127 NN denotes SARS
T15 127-128 -RRB- denotes )
T16 129-132 CC denotes and
T17 133-139 NNP denotes Middle
T18 140-144 NNP denotes East
T19 145-156 JJ denotes respiratory
T20 157-165 NN denotes syndrome
T21 166-167 -LRB- denotes (
T22 167-171 NNS denotes MERS
T23 171-172 -RRB- denotes )
T24 173-186 NNS denotes coronaviruses
T25 187-188 -LRB- denotes (
T26 188-192 NNS denotes CoVs
T27 192-193 -RRB- denotes )
T28 194-197 VBP denotes are
T29 198-206 JJ denotes zoonotic
T30 207-216 NNS denotes pathogens
T31 217-221 IN denotes with
T32 222-226 JJ denotes high
T33 227-235 NN denotes fatality
T34 236-241 NNS denotes rates
T35 242-245 CC denotes and
T36 246-254 JJ denotes pandemic
T37 255-264 NN denotes potential
T38 266-273 NN denotes Vaccine
T39 274-285 NN denotes development
T40 286-293 VBZ denotes focuses
T41 294-296 IN denotes on
T42 297-300 DT denotes the
T43 301-310 JJ denotes principal
T44 311-317 NN denotes target
T45 318-320 IN denotes of
T46 321-324 DT denotes the
T47 325-337 VBG denotes neutralizing
T48 338-345 JJ denotes humoral
T49 346-352 JJ denotes immune
T50 353-361 NN denotes response
T51 361-362 -COMMA- denotes ,
T52 363-366 DT denotes the
T53 367-372 NN denotes spike
T54 373-374 -LRB- denotes (
T55 374-375 NN denotes S
T56 375-376 -RRB- denotes )
T57 377-389 NN denotes glycoprotein
T58 391-402 NN denotes Coronavirus
T59 403-404 NN denotes S
T60 405-413 NNS denotes proteins
T61 414-417 VBP denotes are
T62 418-429 RB denotes extensively
T63 430-442 VBN denotes glycosylated
T64 442-443 -COMMA- denotes ,
R6 T7 T6 arg1Of glycosylation,extensive
R7 T12 T9 arg1Of syndrome,Severe
R8 T12 T10 arg1Of syndrome,acute
R9 T12 T11 arg1Of syndrome,respiratory
R0 T0 T1 arg1Of Vulnerabilities,in
R1 T4 T1 arg2Of shields,in
R2 T4 T2 arg1Of shields,coronavirus
R3 T4 T3 arg1Of shields,glycan
R4 T0 T5 arg1Of Vulnerabilities,despite
R5 T7 T5 arg2Of glycosylation,despite
R10 T12 T13 arg1Of syndrome,(
R11 T14 T13 arg2Of SARS,(
R12 T15 T13 arg3Of ),(
R13 T12 T16 arg1Of syndrome,and
R14 T20 T16 arg2Of syndrome,and
R15 T18 T17 arg1Of East,Middle
R16 T20 T18 arg1Of syndrome,East
R17 T20 T19 arg1Of syndrome,respiratory
R18 T20 T21 arg1Of syndrome,(
R19 T22 T21 arg2Of MERS,(
R20 T23 T21 arg3Of ),(
R21 T28 T24 arg1Of are,coronaviruses
R22 T24 T25 arg1Of coronaviruses,(
R23 T26 T25 arg2Of CoVs,(
R24 T27 T25 arg3Of ),(
R25 T16 T28 arg1Of and,are
R26 T30 T28 arg2Of pathogens,are
R27 T30 T29 arg1Of pathogens,zoonotic
R28 T30 T31 arg1Of pathogens,with
R29 T35 T31 arg2Of and,with
R30 T34 T32 arg1Of rates,high
R31 T34 T33 arg1Of rates,fatality
R32 T34 T35 arg1Of rates,and
R33 T37 T35 arg2Of potential,and
R34 T37 T36 arg1Of potential,pandemic
R35 T39 T38 arg1Of development,Vaccine
R36 T39 T40 arg1Of development,focuses
R37 T40 T41 arg1Of focuses,on
R38 T44 T41 arg2Of target,on
R39 T44 T42 arg1Of target,the
R40 T44 T43 arg1Of target,principal
R41 T44 T45 arg1Of target,of
R42 T50 T45 arg2Of response,of
R43 T50 T46 arg1Of response,the
R44 T50 T47 arg1Of response,neutralizing
R45 T50 T48 arg1Of response,humoral
R46 T50 T49 arg1Of response,immune
R47 T50 T51 arg1Of response,","
R48 T57 T51 arg2Of glycoprotein,","
R49 T57 T52 arg1Of glycoprotein,the
R50 T57 T53 arg1Of glycoprotein,spike
R51 T53 T54 arg1Of spike,(
R52 T55 T54 arg2Of S,(
R53 T56 T54 arg3Of ),(
R54 T60 T58 arg1Of proteins,Coronavirus
R55 T60 T59 arg1Of proteins,S
R56 T60 T61 arg1Of proteins,are
R57 T63 T61 arg2Of glycosylated,are
R58 T63 T62 arg1Of glycosylated,extensively
R59 T60 T63 arg2Of proteins,glycosylated
R60 T63 T64 arg1Of glycosylated,","

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T1 377-389 Body_part denotes glycoprotein http://purl.org/sig/ont/fma/fma62925
T2 405-413 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 377-389 Chemical denotes glycoprotein http://purl.obolibrary.org/obo/CHEBI_17089
T2 405-413 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T1 88-121 Species denotes Severe acute respiratory syndrome NCBItxid:694009
T2 123-127 Species denotes SARS NCBItxid:694009
T3 167-171 Species denotes MERS NCBItxid:1335626

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T1 0-77 Sentence denotes Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
T2 79-87 Sentence denotes Abstract
T3 88-265 Sentence denotes Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential.
T4 266-390 Sentence denotes Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotein.

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 88-121 Disease denotes Severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T2 123-127 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
2 19-30 Species denotes coronavirus Tax:11118
3 31-37 Chemical denotes glycan MESH:D011134
39 88-121 Disease denotes Severe acute respiratory syndrome MESH:D045169
40 123-127 Disease denotes SARS MESH:D045169
25 133-186 Species denotes Middle East respiratory syndrome (MERS) coronaviruses Tax:1335626
68 173-186 Species denotes coronaviruses Tax:11118
69 188-192 Species denotes CoVs Tax:11118
26 188-192 Species denotes CoVs Tax:11118
41 198-206 Disease denotes zoonotic MESH:D015047
33 367-372 Gene denotes spike Gene:43740568
27 391-402 Species denotes Coronavirus Tax:11118

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T1 373-389 Protein denotes (S) glycoprotein https://www.uniprot.org/uniprot/Q9QAS2|https://www.uniprot.org/uniprot/Q9QAR5|https://www.uniprot.org/uniprot/Q9QAQ8|https://www.uniprot.org/uniprot/Q9IW04|https://www.uniprot.org/uniprot/Q9IKD1|https://www.uniprot.org/uniprot/Q990M4|https://www.uniprot.org/uniprot/Q990M3|https://www.uniprot.org/uniprot/Q990M2|https://www.uniprot.org/uniprot/Q990M1|https://www.uniprot.org/uniprot/Q91AV1|https://www.uniprot.org/uniprot/Q91A26|https://www.uniprot.org/uniprot/Q8V436|https://www.uniprot.org/uniprot/Q8JSP8|https://www.uniprot.org/uniprot/Q8BB25|https://www.uniprot.org/uniprot/Q86623|https://www.uniprot.org/uniprot/Q85088|https://www.uniprot.org/uniprot/Q85087|https://www.uniprot.org/uniprot/Q80BV6|https://www.uniprot.org/uniprot/Q7TFB1|https://www.uniprot.org/uniprot/Q7TFA2|https://www.uniprot.org/uniprot/Q7TA19|https://www.uniprot.org/uniprot/Q7T6T3|https://www.uniprot.org/uniprot/Q7T696|https://www.uniprot.org/uniprot/Q77NC4|https://www.uniprot.org/uniprot/Q6TNF9|https://www.uniprot.org/uniprot/Q6R1L7|https://www.uniprot.org/uniprot/Q6QU82|https://www.uniprot.org/uniprot/Q6Q1S2|https://www.uniprot.org/uniprot/Q696Q6|https://www.uniprot.org/uniprot/Q66291|https://www.uniprot.org/uniprot/Q66290|https://www.uniprot.org/uniprot/Q66199|https://www.uniprot.org/uniprot/Q66177|https://www.uniprot.org/uniprot/Q66176|https://www.uniprot.org/uniprot/Q66174|https://www.uniprot.org/uniprot/Q65984|https://www.uniprot.org/uniprot/Q5MQD0|https://www.uniprot.org/uniprot/Q5I5X9|https://www.uniprot.org/uniprot/Q5DIY0|https://www.uniprot.org/uniprot/Q5DIX9|https://www.uniprot.org/uniprot/Q5DIX8|https://www.uniprot.org/uniprot/Q5DIX7|https://www.uniprot.org/uniprot/Q52PA3|https://www.uniprot.org/uniprot/Q4U5G0|https://www.uniprot.org/uniprot/Q3T8J0|https://www.uniprot.org/uniprot/Q3LZX1|https://www.uniprot.org/uniprot/Q3I5J5|https://www.uniprot.org/uniprot/Q14EB0|https://www.uniprot.org/uniprot/Q0ZME7|https://www.uniprot.org/uniprot/Q0Q4F2|https://www.uniprot.org/uniprot/Q0Q475|https://www.uniprot.org/uniprot/Q0Q466|https://www.uniprot.org/uniprot/Q0GNB8|https://www.uniprot.org/uniprot/Q02385|https://www.uniprot.org/uniprot/Q02167|https://www.uniprot.org/uniprot/Q01977|https://www.uniprot.org/uniprot/Q008X4|https://www.uniprot.org/uniprot/P89344|https://www.uniprot.org/uniprot/P89343|https://www.uniprot.org/uniprot/P89342|https://www.uniprot.org/uniprot/P59594|https://www.uniprot.org/uniprot/P36334|https://www.uniprot.org/uniprot/P36300|https://www.uniprot.org/uniprot/P33470|https://www.uniprot.org/uniprot/P30208|https://www.uniprot.org/uniprot/P30207|https://www.uniprot.org/uniprot/P30206|https://www.uniprot.org/uniprot/P30019|https://www.uniprot.org/uniprot/P27655|https://www.uniprot.org/uniprot/P25194|https://www.uniprot.org/uniprot/P25193|https://www.uniprot.org/uniprot/P25192|https://www.uniprot.org/uniprot/P25191|https://www.uniprot.org/uniprot/P25190|https://www.uniprot.org/uniprot/P24413|https://www.uniprot.org/uniprot/P23052|https://www.uniprot.org/uniprot/P22432|https://www.uniprot.org/uniprot/P18450|https://www.uniprot.org/uniprot/P17662|https://www.uniprot.org/uniprot/P15777|https://www.uniprot.org/uniprot/P15423|https://www.uniprot.org/uniprot/P12722|https://www.uniprot.org/uniprot/P12651|https://www.uniprot.org/uniprot/P12650|https://www.uniprot.org/uniprot/P11225|https://www.uniprot.org/uniprot/P11224|https://www.uniprot.org/uniprot/P11223|https://www.uniprot.org/uniprot/P10033|https://www.uniprot.org/uniprot/P0DTC2|https://www.uniprot.org/uniprot/P07946|https://www.uniprot.org/uniprot/P05135|https://www.uniprot.org/uniprot/P05134|https://www.uniprot.org/uniprot/O90304|https://www.uniprot.org/uniprot/O39227|https://www.uniprot.org/uniprot/K9N5Q8|https://www.uniprot.org/uniprot/A3EXG6|https://www.uniprot.org/uniprot/A3EXD0|https://www.uniprot.org/uniprot/A3EX94|https://www.uniprot.org/uniprot/Q4ZJS1
T100 403-413 Protein denotes S proteins https://www.uniprot.org/uniprot/Q9UIP0|https://www.uniprot.org/uniprot/Q9UIN9|https://www.uniprot.org/uniprot/Q9UIN8|https://www.uniprot.org/uniprot/Q9UIN7|https://www.uniprot.org/uniprot/Q9UIN6|https://www.uniprot.org/uniprot/Q9UBH8|https://www.uniprot.org/uniprot/Q9NRH8|https://www.uniprot.org/uniprot/Q9NRH7|https://www.uniprot.org/uniprot/Q9NRH6|https://www.uniprot.org/uniprot/Q9NRH5|https://www.uniprot.org/uniprot/Q9NRH4|https://www.uniprot.org/uniprot/Q9NPG5|https://www.uniprot.org/uniprot/Q9NPE0|https://www.uniprot.org/uniprot/Q9NP52|https://www.uniprot.org/uniprot/Q95IF9|https://www.uniprot.org/uniprot/Q8N5P3|https://www.uniprot.org/uniprot/Q8IZU6|https://www.uniprot.org/uniprot/Q8IZU5|https://www.uniprot.org/uniprot/Q8IZU4|https://www.uniprot.org/uniprot/Q86Z04|https://www.uniprot.org/uniprot/Q7YR44|https://www.uniprot.org/uniprot/Q7LA71|https://www.uniprot.org/uniprot/Q7LA70|https://www.uniprot.org/uniprot/Q5STD2|https://www.uniprot.org/uniprot/Q5SQ85|https://www.uniprot.org/uniprot/Q1XI16|https://www.uniprot.org/uniprot/Q1XI12|https://www.uniprot.org/uniprot/Q15517|https://www.uniprot.org/uniprot/O43509|https://www.uniprot.org/uniprot/O19084|https://www.uniprot.org/uniprot/B0UYZ7|https://www.uniprot.org/uniprot/B0S7V2|https://www.uniprot.org/uniprot/A5A6L9

LitCovid-sample-PD-GO-BP-0

Id Subject Object Predicate Lexical cue
T1 64-77 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T2 338-361 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune response
T3 346-361 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-sample-GO-BP

Id Subject Object Predicate Lexical cue
T1 64-77 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T2 338-361 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune response
T3 346-361 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 64-77 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T2 338-361 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune response
T3 346-361 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-77 Sentence denotes Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
T2 79-87 Sentence denotes Abstract
T3 88-265 Sentence denotes Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential.
T4 266-390 Sentence denotes Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotein.